Search clinical trials for: Emoxypine succinate

Total 425 results

Pharmasoft

Completed

Study of Efficacy and Safety of MEXIDOL®

Ischemic Stroke
Pharmasoft

Completed

MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure

Ischemic Stroke, Acute

Russian Federation
Changchun Huayang High-tech Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Unknown

Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease

Alzheimer's Disease

China
Hutchison Medipharma Limited

Unknown

HMPL-813 in Treating Patients With Glioblastoma

Glioblastoma

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes

Diabetes Mellitus, Type 2

China
Shanghai Fosun Pharmaceutical Industrial Development...

Recruiting

A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients

Advanced Solid Tumor | Advanced Cancer | Lung Cancer, Nonsmall Cell

China
Astellas Pharma Inc

Completed

Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy Volunteers

Healthy Volunteers | Pharmacokinetics of Solifenacin Succinate | Bioavailability of Solifenacin Succinate

United States
Huashan Hospital

Completed

the Efficacy and Safety of Vitamin C for Iron Supplementation in Adult IDA Patients

Anemia, Iron-Deficiency

China
Astellas Pharma Europe B.V.

Completed

A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)

Pediatric | Neurogenic Detrusor Overactivity

United States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
Astellas Pharma Inc

Completed

Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents

Urinary Bladder, Overactive

Sweden, United Kingdom, Belgium, Denmark
Astellas Pharma Europe B.V.

Completed

A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076 (LEOPARD)

Urinary Bladder, Overactive

Belgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
Center Eugene Marquis

Terminated

Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer (VesiCaP)

Overactive Bladder

France
Research Center, LLC

Completed

Clinical Evaluation of Effectiveness and Safety of Dietary Supplement Potensa in Men With Erectile Dysfunction

Erectile Dysfunction

Russian Federation
Astellas Pharma Inc

Completed

A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet Formulation

Healthy Volunteers | Pharmacokinetics of Solifenacin Succinate

United States
Sanofi

Completed

An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Depressive Disorder

France, Canada, Germany, Portugal, Czech Republic, Mexico, Croatia, Chile
Zhejiang Provincial Center for Disease Control...
China National Biotec Group Company Limited

Not yet recruiting

Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children ( DTaP/DT ) (DTaP/DT)

Vaccine Reaction

China
Sanofi

Completed

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Depressive Disorder

Canada, Germany, Portugal, Estonia, Mexico, Croatia, Chile, Czechia
Sanofi

Completed

A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression

Depressive Disorder

United States
Sanofi

Completed

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Depressive Disorder

United States
Sanofi

Completed

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Depressive Disorder

United States
Beijing Tiantan Hospital

Unknown

Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE) (FAVORITE)

Iron-deficiency | Cerebral Infarction | Dementia, Vascular | TIA | Vascular Cognitive Impairment

China
POLYSAN Scientific & Technological Pharmaceutical...
Atlant Clinical Ltd.

Completed

Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients

Metabolic Acidosis

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

A Pooled Analysis of the Data From Two Studies of Ammonium Succinate for Menopausal Symptoms

Menopause Related Conditions

Russian Federation
Seoul National University Hospital
Pfizer; Seoul National University Bundang Hospital; Korea Cancer Center Hospital

Terminated

Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen

Breast Neoplasms | Hot Flashes

Korea, Republic of
Stamford Hospital

Withdrawn

Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder

Overactive Bladder | Urge Incontinence | Urinary Urge

United States
Procter and Gamble
Consumer Healthcare Products Association

Completed

Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children

Allergic Rhinitis | Upper Respiratory Infection

United States
Brigham and Women's Hospital
University of California, Los Angeles; POM Wonderful LLC

Completed

Impact of Antioxidant Juice Intake on Brain Injury and Placental Pathology in Infants With Intrauterine Growth Restriction (IUGR)

Intrauterine Growth Restriction

United States
Beni-Suef University

Completed

Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms

Voiding Disorders

Egypt
Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

Neurogenic Detrusor Overactivity

United States, Belgium, Brazil, Denmark, Hungary, Korea, Republic of, Mexico, Philippines, Poland, Turkey
Zhejiang Provincial Center for Disease Control...
China National Biotec Group Company Limited

Not yet recruiting

Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children (DTaP/DT)

Vaccine Reaction

China
Astellas Pharma Inc

Completed

Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms (VOLT)

Urinary Bladder, Overactive

United States
University of South Florida

Withdrawn

Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease

Urinary Incontinence | Parkinson's Disease

United States
Saniona

Completed

A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate

Phase 1

Germany
Shengjing Hospital

Not yet recruiting

Iron Deficiency Anemia in Twin Pregnancies

Anemia, Iron-Deficiency
Astellas Pharma Inc
Astellas Pharma Korea, Inc.

Completed

A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder

Overactive Bladder

Korea, Republic of
Jerry Zimmerman
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Stress Hydrocortisone In Pediatric Septic Shock (SHIPSS)

Septic Shock

United States, Canada, China, Israel, Japan, Malaysia, Pakistan, Saudi Arabia, Singapore, Vietnam
Astellas Pharma Inc

Completed

Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms (SUNRISE)

Urinary Bladder, Overactive

France, United Kingdom, Belgium, Germany, Spain, Portugal, Greece, Russian Federation, Czech Republic, Poland, Hungary, Italy, Slovakia, Egypt
Pfizer

Completed

Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder

Major Depressive Disorder

Canada, United States, Colombia, Croatia, Estonia, Finland, Poland, France, Slovakia, Chile, Latvia, Lithuania, Romania, South Africa
Wyeth is now a wholly owned subsidiary of Pfizer
Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder

Major Depressive Disorder

United States
Advanced Research Network
Astellas Pharma US, Inc.

Terminated

VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate

Over-Active Bladder

United States
Astellas Pharma Inc

Completed

A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB) (VENUS)

Urinary Bladder, Overactive

United States
Zhongnan Hospital

Recruiting

A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors

Hematological Malignancy | Cancer-Related Anemia

China
Astellas Pharma Europe B.V.

Completed

A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels

Healthy Subjects | Bioavailability | Phase 1

Germany
University of South Florida

Completed

Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease (URGE-PD)

Overactive Bladder in Parkinson's Disease

United States
Astellas Pharma Inc

Completed

A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy

Urinary Incontinence

United States, Canada
Peking University

Unknown

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Lymphoma | Anemia | Hematopoietic Stem Cell Transplantation

China
Astellas Pharma Inc

Completed

Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder (VERSUS)

Urinary Bladder, Overactive

United States
Pfizer

Completed

Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)

Major Depressive Disorder
Astellas Pharma Inc

Completed

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Overactive Bladder | Neurogenic Detrusor Overactivity

Belgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom

Search clinical trials for: Emoxypine succinate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations